Dr. Carlos Buesa, Oryzon Genomics CEO, to be a Keynote Speaker at the 15th Annual Global Discovery-Summit 2015 in Lisbon, Portugal
Barcelona, Spain and Cambridge, MA - March 2, 2015
Oryzon Genomics, a private clinical stage biopharmaceutical company focused on epigenetic based therapeutics in oncology and neurodegenerative diseases, today announced that its CEO, Dr. Carlos Buesa will be presenting as a keynote speaker at the 15th Annual Global Discovery-Summit 2015 at Grande Real Villa Italia Hotel in Cascais, Lisbon, Portugal, to be held on March 16-17, 2015. The presentation is titled “Evaluating Epigenetic Approaches for Alzheimer's Disease”. The Keynote Presentation is scheduled for 8:00 am CET, Tuesday, March 17, 2015 at the Principe de Saboia I ballroom.